Koninklijke Philips Income After Taxes 2010-2024 | PHG

Koninklijke Philips annual/quarterly income after taxes history and growth rate from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
  • Koninklijke Philips income after taxes for the quarter ending September 30, 2024 was $0.200B, a 883.55% decline year-over-year.
  • Koninklijke Philips income after taxes for the twelve months ending September 30, 2024 was $-0.096B, a 116.55% decline year-over-year.
  • Koninklijke Philips annual income after taxes for 2023 was $-0.491B, a 71.18% decline from 2022.
  • Koninklijke Philips annual income after taxes for 2022 was $-1.705B, a 335.44% decline from 2021.
  • Koninklijke Philips annual income after taxes for 2021 was $0.724B, a 47.4% decline from 2020.
Koninklijke Philips Annual Income After Taxes
(Millions of US $)
2023 $-491
2022 $-1,705
2021 $724
2020 $1,376
2019 $1,335
2018 $1,547
2017 $1,162
2016 $1,175
2015 $426
2014 $211
2013 $1,587
2012 $612
2011 $-1,103
2010 $1,904
2009 $485
Koninklijke Philips Quarterly Income After Taxes
(Millions of US $)
2024-09-30 $200
2024-06-30 $335
2023-06-30 $81
2023-03-31 $-712
2022-06-30 $-26
2021-06-30 $78
2020-06-30 $235
2019-06-30 $292
2018-06-30 $222
2017-06-30 $176
2016-12-31 $601
2016-09-30 $305
2016-06-30 $259
2016-03-31 $11
2015-12-31 $-131
2015-09-30 $260
2015-06-30 $251
2015-03-31 $46
2014-12-31 $-72
2014-09-30 $-178
2014-06-30 $299
2014-03-31 $162
2013-12-31 $631
2013-09-30 $350
2013-06-30 $405
2013-03-31 $202
2012-12-31 $-203
2012-09-30 $219
2012-06-30 $218
2012-03-31 $378
2011-12-31 $223
2011-09-30 $164
2011-06-30 $-1,790
2011-03-31 $299
2010-12-31 $643
2010-09-30 $672
2010-06-30 $320
2010-03-31 $269
2009-12-31 $-638
2009-09-30 $196
2009-06-30 $1,001
2009-03-31 $-73
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $23.480B $19.663B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $196.757B 25.10
Stryker (SYK) United States $136.750B 30.82
Boston Scientific (BSX) United States $131.731B 37.87
EssilorLuxottica (ESLOY) France $109.710B 0.00
Medtronic (MDT) Ireland $102.865B 15.28
Haleon (HLN) United Kingdom $42.732B 27.76
Lonza Group Ag (LZAGY) Switzerland $42.382B 0.00
GE HealthCare Technologies (GEHC) United States $35.810B 18.57
ResMed (RMD) United States $33.540B 27.56
Terumo (TRUMY) Japan $28.681B 40.51
Zimmer Biomet Holdings (ZBH) United States $20.795B 13.24
Insulet (PODD) United States $18.017B 71.75
Baxter (BAX) United States $14.940B 9.72
Smith & Nephew SNATS (SNN) United Kingdom $10.667B 0.00
BellRing Brands (BRBR) United States $9.606B 38.65
Bio-Rad Laboratories (BIO) United States $9.131B 31.03
Demant (WILYY) Denmark $8.251B 0.00
Lantheus Holdings (LNTH) United States $6.174B 14.35
Haemonetics (HAE) United States $3.938B 19.22
ICU Medical (ICUI) United States $3.868B 36.83
Prestige Consumer Healthcare (PBH) United States $3.840B 19.10
Perrigo (PRGO) Ireland $3.547B 10.44
Envista Holdings (NVST) United States $3.289B 24.50
QuidelOrtho (QDEL) United States $3.029B 19.50
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.863B 18.36
Neogen (NEOG) United States $2.587B 29.85
LeMaitre Vascular (LMAT) United States $2.057B 49.98
Green Thumb Industries (GTBIF) United States $1.724B 30.17
AtriCure (ATRC) United States $1.482B 0.00
InMode (INMD) Israel $1.424B 8.57
Maravai LifeSciences Holdings (MRVI) United States $1.386B 0.00
AdaptHealth (AHCO) United States $1.305B 9.33
BioLife Solutions (BLFS) United States $1.214B 0.00
Curaleaf Holdings (CURLF) Canada $1.066B 0.00
Owens & Minor (OMI) United States $0.991B 7.74
CeriBell (CBLL) United States $0.926B 0.00
Phibro Animal Health (PAHC) United States $0.840B 14.81
Evolus (EOLS) United States $0.704B 0.00
Capricor Therapeutics (CAPR) United States $0.680B 0.00
VAREX IMAGING (VREX) United States $0.594B 26.20
Omeros (OMER) United States $0.570B 0.00
Surmodics (SRDX) United States $0.567B 0.00
Verano Holdings (VRNOF) United States $0.502B 0.00
Cresco Labs (CRLBF) United States $0.463B 0.00
Quanterix (QTRX) United States $0.415B 0.00
Valneva SE (VALN) France $0.384B 0.00
ZimVie (ZIMV) United States $0.382B 32.16
Biote (BTMD) United States $0.328B 7.18
Viemed Healthcare (VMD) United States $0.317B 30.11
Canopy Growth (CGC) Canada $0.314B 0.00
Cerus (CERS) United States $0.292B 0.00
Sanara MedTech (SMTI) United States $0.289B 0.00
High Tide (HITI) Canada $0.269B 110.67
OraSure Technologies (OSUR) United States $0.264B 17.70
Zynex (ZYXI) United States $0.249B 52.07
Aurora Cannabis (ACB) Canada $0.247B 0.00
Organigram Holdings (OGI) Canada $0.209B 0.00
Utah Medical Products (UTMD) United States $0.208B 14.37
MacroGenics (MGNX) United States $0.207B 0.00
TerrAscend (TSNDF) Canada $0.205B 0.00
Sanuwave Health (SNWV) United States $0.188B 2.64
Brainsway (BWAY) Israel $0.180B 95.80
TriSalus Life Sciences (TLSI) United States $0.152B 0.00
Jin Medical (ZJYL) China $0.149B 0.00
FitLife Brands (FTLF) United States $0.148B 18.59
Quipt Home Medical (QIPT) United States $0.125B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.097B 0.00
Fonar (FONR) United States $0.096B 10.79
Veru (VERU) United States $0.095B 0.00
InterCure (INCR) Israel $0.072B 0.00
Rockwell Medical (RMTI) United States $0.072B 37.00
Jushi Holdings (JUSHF) United States $0.065B 0.00
Ayr Wellness (AYRWF) United States $0.060B 0.00
Apyx Medical (APYX) United States $0.059B 0.00
Exagen (XGN) United States $0.055B 0.00
Cytosorbents (CTSO) United States $0.050B 0.00
Modular Medical (MODD) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.047B 0.00
Safety Shot (SHOT) United States $0.045B 0.00
Allurion Technologies (ALUR) United States $0.027B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
Nephros (NEPH) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Trinity Biotech (TRIB) Ireland $0.007B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Agape ATP (ATPC) $0.005B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.84
SNDL (SNDL) Canada $0.000B 0.00